WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
[SCHEDULE 13D/A CUSIP No. Page 2 1 NAME OF REPORTING PERSONS Warburg Pincus Private Equity X, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) (b)]
[SCHEDULE 13D/A CUSIP No. Page 2 1 NAME OF REPORTING PERSONS Warburg Pincus Private Equity X, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) (b)]
[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be (Continued on the Following Pages) 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. 3. 4. Delaware]
[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be (Continued on the Following Pages) 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. 3. 4. Delaware]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 81,341,504 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739%]